在帕金森病中,虚弱和疾病进展之间的关系:一项为期3年的纵向研究
Matteo Costanzo1,2, Marco Canevelli2, Maria Ilenia De Bartolo2,3
1Department of Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.
GeroScience
|February 23, 2026
概括
脆弱性预测帕金森病 (PD) 的结果会更差. 较高的脆弱性得分表明PD患者的运动并发症增加,认知能力下降和死亡风险增加,突出显示脆弱性是关键的预后生物标志物.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 临床医学 临床医学
背景情况:
- 帕金森病 (PD) 在临床表现和进展方面表现出显著的变化.
- 脆弱,生物衰老的标志物,影响神经退行性疾病的结果.
- 现有的横截面数据表明虚弱影响PD症状,但其纵向预后值是未知的.
研究的目的:
- 调查帕金森病中虚弱的纵向预后相关性.
- 为了确定虚弱是否预测PD患者在3年内临床进展,运动并发症和死亡率.
主要方法:
- 这是一项为期3年的单中心队列研究,包括109名帕金森病患者.
- 使用50项脆弱指数 (FI) 来评估脆弱性.
- 临床结局包括MDS-UPDRS,非运动症状尺度,MoCA,Hoehn & Yahr阶段,以及通过回归和混合效应模型分析的莱沃多巴每日相当剂量 (LEDD).
主要成果:
- 较高的基线虚弱指数 (FI) 独立预测了运动并发症的严重程度增加和恶化.
- 虚弱性显示出增加非运动症状负担和认知能力下降的趋势.
- 脆弱的患者经历了更大的临床恶化,更高的LEDD需求,与不那么脆弱的个体相比,死亡率显著增加.
结论:
- 虚弱是不良临床轨迹和帕金森病死亡率增加的重要预测因素.
- 脆弱性是PD管理中的一个有价值的预后生物标志物.
- 将脆弱性评估整合到常规帕金森病护理中可以提高风险分层和个性化治疗策略.
相关概念视频
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Longitudinal Research
13.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.5K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278


